UnitedHealth Group Incorporated (UNH)

517.40 1.99%
Jul 04 close; Powered by IEX
Pros
Revenue growth higher than the industry and sector averages
Company’s profitability is improving
Forward dividend yield higher than the industry and sector averages
Buy analyst rating
Average analyst stock price above current stock price
Cons
Forward P/E ratio high relative to industry peers
Forward P/B ratio high relative to industry peers
Forward P/S ratio high relative to industry peers

Pros

  1. UNH quarterly revenue growth was 14.20%, higher than the industry and sector average revenue growth (12.02% and 7.51%, respectively). See UNH revenue growth chart.
  2. UNH profitability is improving. The YoY profit margin change was 0.10 percentage points. See UNH profitability chart.
  3. UNH forward dividend yield is 1.19%, higher than the industry (0.46%) and sector (0.20%) forward dividend yields. See UNH forward dividend chart.
  4. UNH average analyst rating is Strong Buy. See UNH analyst rating chart.
  5. UNH average analyst price target ($576.08) is above its current price ($517.03). See UNH price target chart.

Cons

  1. UNH forward P/E ratio is 22.89, which is high compared to its industry peers’ P/E ratios. See UNH forward P/E ratio chart.
  2. UNH Price/Book ratio is 6.64, which is high compared to its industry peers’ P/B ratios. See UNH forward Price/Book ratio chart.
  3. UNH Price/Sales ratio is 1.57, which is high compared to its industry peers’ P/S ratios. See UNH forward Price/Sales ratio chart.